BANCOLOMBIA S.A. TO DELIST NOTES FROM THE NEW YORK STOCK EXCHANGE
Codexis (NASDAQ: CDXS), a provider of enzymatic solutions for therapeutics manufacturing, has announced its participation in the upcoming Jefferies Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Codexis (NASDAQ: CDXS), a provider of enzymatic solutions for therapeutics manufacturing, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The event will take place from June 3-5, 2025 in New York.
The company's management will engage in a fireside chat on June 4, 2025, at 3:10 pm ET. Investors can access a live webcast of the presentation through Codexis's investor relations website, with a replay available for 90 days after the event.
Details
News Market Reaction – CIB
On Jul 23, the first trading day after this news, CIB closed 0.65% above the previous close.
Data tracked by StockTitan Argus for the Jul 23 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The decision to voluntarily delist the Notes from the NYSE and list the Notes on the SGX was made after careful consideration of the effects of being listed on each respective exchange by the board of directors of Bancolombia.
Bancolombia has notified the NYSE of its intention to voluntarily delist the Notes. Bancolombia currently anticipates that it will file with the
The American Depositary Shares of Grupo Cibest S.A. ("Grupo Cibest"), Bancolombia's parent company, will continue to trade on the NYSE under the symbol "CIB", and as a result Grupo Cibest will continue to be required to file periodic reports under the Exchange Act.
Contacts | ||||
Mauricio Botero Wolff | Catalina Tobón Rivera | |||
Strategy and Finance VP | IR Director | |||
Tel: (57 604) 404 0858 | Tel (57 601) 4885950 | |||
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.